BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000550 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
256,416
Total Value
$6,856,736.75
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 65,921 | $8.45 | $557,032.45 | 79,662 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 17,167 | $16.75 | $287,547.25 | 96,829 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 15, 2026 | Sale | 88,737 | $66.62 | $5,911,241.88 | 8,092 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 15, 2026 | Sale | 1,503 | $67.14 | $100,915.18 | 6,589 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 65,921 | $0.00 | $0.00 | 39,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 17,167 | $0.00 | $0.00 | 34,334 | Direct | โ | View Details |